Stay updated on Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page revision was updated to version 3.6.5, indicating a minor update to the record's metadata. No substantive study content appears to be changed.
    Difference
    0.1%
    Check dated 2026-08-11T08:23:21.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.3 to v3.6.4, indicating a minor platform or content refresh with no changes to the study information.
    Difference
    0.1%
    Check dated 2026-07-28T05:13:38.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The page shows revision v3.6.3 replacing v3.6.2, indicating an internal update to the system or documentation. This change does not modify the study details presented on the page.
    Difference
    0.1%
    Check dated 2026-07-06T15:50:20.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.0 to v3.6.2. This indicates a minor update to the page metadata associated with the study record.
    Difference
    0.1%
    Check dated 2026-06-29T10:54:43.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The study record adds a recruitment-closed notice and new help sections for readers, standardizes the Intervention/Treatment heading, and updates the site revision to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T08:19:05.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.4 to v3.5.5, indicating a new version of the page. This appears to be a minor update rather than a change to substantive study details or primary content.
    Difference
    0.1%
    Check dated 2026-06-08T03:46:40.000Z thumbnail image

Stay in the know with updates to Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial page.